Asia Pacific Dietary Supplements Market Size to register a growth of 10.3% CAGR during the forecast period

10-05-2018 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report Asia Pacific Dietary Supplements Market, published by KBV research, the Asia Pacific Dietary Supplements Market Size would witness market growth of 10.3% CAGR during the forecast period (2017 - 2023). The China market holds the largest market share in Asia Pacific Tablets & Capsules Market by Country in 2016 and would continue to be a dominant market till 2023; growing at a CAGR of 7.6 % during the forecast period.

The Japan market is expected to witness a CAGR of 8.1% during (2017 - 2023) in Asia Pacific Powder System Market. Additionally, The India market is expected to witness a CAGR of 13.1% during (2017 - 2023) in Asia Pacific Soft Gels Market.

The Vitamins & Minerals market holds the largest market share in Asia Pacific Dietary Supplements Market by Ingredients in 2016 and would continue to be a dominant market till 2023. The Amino Acids market is expected to witness a CAGR of 11.6% during (2017 - 2023). Additionally, The Enzymes & Others market is expected to witness a CAGR of 12.2% during (2017 - 2023).

The Adults market holds the largest market share in Malaysia Dietary Supplements Market by End User in 2016 and would continue to be a dominant market till 2023; growing at a CAGR of 11.6 % during the forecast period. The Children market is expected to witness a CAGR of 13% during (2017 - 2023). Additionally, The Infants & Old Age market would attain market value of $729.6 million by 2023.

Full Report: https://www.kbvresearch.com/asia-pacific-dietary-supplements-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key impacting factors of the Asia Pacific Dietary Supplements Market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, The Carlyle Group, GlaxoSmithKline plc, Alticor (Amway), Glanbia, Plc. (Glanbia Nutritionals), Bayer AG, Archer Daniels Midland Company, E. I. Du Pont De Nemours and Company, Nutraceutics Inc., and Pfizer, Inc.